Pharmaceutical Investing Crinetics Pharmaceuticals Doses First Patients in Phase 2 Clinical Trials of CRN00808
Heritage Mining Ltd. Announces Closing of the Second and Final Tranche of its Non-Brokered Private Placement of Units and Flow-Through Units
